BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 34850382)

  • 1. Blue versus white light for transurethral resection of non-muscle invasive bladder cancer.
    Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013776. PubMed ID: 34850382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical electromotive drug administration for non-muscle invasive bladder cancer.
    Jung JH; Gudeloglu A; Kiziloz H; Kuntz GM; Miller A; Konety BR; Dahm P
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011864. PubMed ID: 28898400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blue vs white light for transurethral resection of non-muscle-invasive bladder cancer: an abridged Cochrane Review.
    Maisch P; Koziarz A; Vajgrt J; Narayan V; Kim MH; Dahm P
    BJU Int; 2022 Dec; 130(6):730-740. PubMed ID: 35238145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer.
    Schmidt S; Kunath F; Coles B; Draeger DL; Krabbe LM; Dersch R; Kilian S; Jensen K; Dahm P; Meerpohl JJ
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011935. PubMed ID: 31912907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical gemcitabine for non-muscle invasive bladder cancer.
    Han MA; Maisch P; Jung JH; Hwang JE; Narayan V; Cleves A; Hwang EC; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD009294. PubMed ID: 34125951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narrow band imaging versus white light cystoscopy alone for transurethral resection of non-muscle invasive bladder cancer.
    Lai LY; Tafuri SM; Ginier EC; Herrel LA; Dahm P; Maisch P; Lane GI
    Cochrane Database Syst Rev; 2022 Apr; 4():CD014887. PubMed ID: 35393644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robotic versus open radical cystectomy for bladder cancer in adults.
    Rai BP; Bondad J; Vasdev N; Adshead J; Lane T; Ahmed K; Khan MS; Dasgupta P; Guru K; Chlosta PL; Aboumarzouk OM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011903. PubMed ID: 31016718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robot-assisted vs open radical cystectomy for bladder cancer in adults.
    Rai BP; Bondad J; Vasdev N; Adshead J; Lane T; Ahmed K; Khan MS; Dasgupta P; Guru K; Chlosta PL; Aboumarzouk OM
    BJU Int; 2020 Jun; 125(6):765-779. PubMed ID: 31309688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy for advanced or metastatic urothelial carcinoma.
    Maisch P; Hwang EC; Kim K; Narayan VM; Bakker C; Kunath F; Dahm P
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013774. PubMed ID: 37811690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.
    Narayan V; Kahlmeyer A; Dahm P; Skoetz N; Risk MC; Bongiorno C; Patel N; Hwang EC; Jung JH; Gartlehner G; Kunath F
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012838. PubMed ID: 30036453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative nutrition for the treatment of bladder cancer by radical cystectomy.
    Burden S; Billson HA; Lal S; Owen KA; Muneer A
    Cochrane Database Syst Rev; 2019 May; 5(5):CD010127. PubMed ID: 31107970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-dose intravesical chemotherapy after nephroureterectomy for upper tract urothelial carcinoma.
    Hwang EC; Sathianathen NJ; Jung JH; Kim MH; Dahm P; Risk MC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013160. PubMed ID: 31102534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncoplastic breast-conserving surgery for women with primary breast cancer.
    Nanda A; Hu J; Hodgkinson S; Ali S; Rainsbury R; Roy PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013658. PubMed ID: 34713449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
    Heer R; Lewis R; Duncan A; Penegar S; Vadiveloo T; Clark E; Yu G; Mariappan P; Cresswell J; McGrath J; N'Dow J; Nabi G; Mostafid H; Kelly J; Ramsay C; Lazarowicz H; Allan A; Breckons M; Campbell K; Campbell L; Feber A; McDonald A; Norrie J; Orozco-Leal G; Rice S; Tandogdu Z; Taylor E; Wilson L; Vale L; MacLennan G; Hall E
    Health Technol Assess; 2022 Oct; 26(40):1-144. PubMed ID: 36300825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
    Kunath F; Jensen K; Pinart M; Kahlmeyer A; Schmidt S; Price CL; Lieb V; Dahm P
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD003506. PubMed ID: 31194882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F; Barchetti G; De Berardinis E; Pecoraro M; Salvo V; Simone G; Sciarra A; Leonardo C; Gallucci M; Catalano C; Catto JWF; Panebianco V
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.